PARP inhibitors in metastatic prostate cancer.

Taylor, Amy K; Kosoff, David; Emamekhoo, Hamid; Lang, Joshua M; Kyriakopoulos, Christos E

Taylor, Amy K; Kosoff, David; Emamekhoo, Hamid; Lang, Joshua M; Kyriakopoulos, Christos E.

Afiliação

Taylor AK; Department of Medicine, University of Wisconsin, Madison, WI, United States.
Kosoff D; Department of Medicine, University of Wisconsin, Madison, WI, United States.
Emamekhoo H; University of Wisconsin Carbone Cancer Center, Madison, WI, United States.
Lang JM; Department of Medicine, University of Wisconsin, Madison, WI, United States.
Kyriakopoulos CE; University of Wisconsin Carbone Cancer Center, Madison, WI, United States.

Front Oncol ; 13: 1159557, 2023.

Article em En | MEDLINE | ID: mdl-37168382

Palavras-chave

BRCA; DNA damage repair genes; PARP inhibitor; homologous recombination repair; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google